Author :Sagitta Pharma

Réduire l’empreinte carbone liée aux déplacements professionnels La réduction de l’empreinte carbone issue des déplacements professionnels constitue aujourd’hui un enjeu majeur pour les entreprises engagées dans la transition écologique.Chez Sagitta Pharma, la mobilité représente une part significative des émissions de gaz à effet de serre. Consciente de cet impact, l’entreprise a mis en place une série d’actions concrètes visant à réduire durablement son empreinte environnementale. Ces initiatives s’inscrivent pleinement dans une stratégie RSE (Responsabilité Sociétale des Entreprises) ambitieuse, intégrée à la culture et aux valeurs de Sagitta Pharma. 👉 Découvrez notre politique RSE : Une flotte de véhicules électriques pour accompagner la transition Dans le cadre de son plan de réduction de l’impact carbone, Sagitta Pharma a déployé il y a quelques années déjà une flotte de véhicules hybrides et électriques pour les déplacements professionnels.Cette initiative favorise une mobilité plus responsable, tout en améliorant le confort et la sécurité des collaborateurs.Pour accompagner cette évolution, des bornes de recharge électrique ont été installées sur le parking de l’entreprise, facilitant la recharge sur site. Cette démarche encourage l’adoption de modes de déplacement à faible émission de CO₂, en cohérence avec les objectifs de transition énergétique fixés au niveau national. Une contribution carbone certifiée : 42 tonnes de CO₂ compensées Au-delà de la réduction directe des émissions, Sagitta Pharma agit pour une neutralité carbone mesurable et vérifiable.L’entreprise a obtenu une certification WeNow, attestant d’une contribution carbone de 42 tonnes de CO₂ compensées pour l’année 2025. Voir notre certificat contribution carbone 2025 : Cette certification garantit le financement de projets environnementaux certifiés à impact réel, favorisant la lutte contre le changement climatique à l’échelle internationale et locale. Soutien à un projet d’hydroélectricité certifié par l’ONU Parmi les projets soutenus figure Small Hydro – ID 1280, un projet d’hydroélectricité à petite échelle certifié par l’Organisation des Nations Unies. Ce type de projet repose sur la production d’électricité renouvelable à partir d’installations hydrauliques de faible puissance. Il contribue à : La certification ONU garantit que le projet respecte des méthodologies strictes en matière de réduction d’émissions et de suivi des impacts. Contribution à la reforestation en forêt communale française La contribution carbone de Sagitta Pharma inclut également le financement de la plantation de 11 arbres en forêt communale française, au sein de forêts gérées par l’Office National des Forêts au cœur des montagnes de l’Ain. Ces actions participent : Une démarche RSE intégrée à notre marque employeur Au-delà de l’impact environnemental, ces initiatives s’inscrivent dans une vision plus large de la responsabilité de l’entreprise en tant qu’employeur. La mise en œuvre d’actions concrètes en faveur de la mobilité durable contribue à créer un cadre de travail en phase avec les enjeux environnementaux actuels et les attentes sociétales. Agir de manière mesurable et vérifiable La démarche environnementale de Sagitta Pharma repose sur des actions mesurables, certifiées et vérifiables, combinant : Cette approche vise à inscrire la transition environnementale dans une logique de progrès continu, fondée sur des engagements concrets. FAQ – Mobilité durable et engagement carbone 1. Qu’est-ce que la mobilité durable ?La mobilité durable désigne l’ensemble des pratiques et technologies visant à réduire l’impact environnemental des déplacements, notamment via les transports doux ou électriques. 2. Pourquoi Sagitta Pharma s’engage-t-elle dans la mobilité durable ?Parce que certains déplacements professionnels représentent une part importante des émissions de CO₂, et que Sagitta Pharma souhaite agir concrètement pour limiter son empreinte carbone. 3. Que représente la contribution carbone WeNow ?C’est une certification attestant que Sagitta Pharma compense une partie de ses émissions en finançant des projets écologiques reconnus. 4. Quels sont les bénéfices d’une flotte électrique ?Une flotte hybride et électrique réduit les émissions directes de CO₂ et confirme la responsabilité de l’entreprise. 5. Qu’est-ce qu’un projet d’hydroélectricité certifié par l’ONU ?Il s’agit d’un projet utilisant la force de l’eau pour produire de l’électricité renouvelable, validé selon des standards internationaux stricts. 6. En quoi la reforestation contribue-t-elle à la neutralité carbone ?Les arbres captent et stockent le CO₂ de l’atmosphère, compensant ainsi une partie des émissions humaines. Conclusion : Sagitta Pharma, un acteur engagé pour une mobilité durable À travers ses actions en faveur de la mobilité durable, de la réduction carbone, et de la compensation environnementale, Sagitta Pharma confirme son engagement envers un avenir plus responsable.L’entreprise démontre qu’il est possible de concilier performance économique, bien-être des collaborateurs, et respect de l’environnement, dans une logique d’amélioration continue.

After six months of collaboration, the Sagitta Pharma CSR partnership with PharmaGreen has produced its first concrete and measurable results, illustrating the laboratory's commitment to a more responsible pharmaceutical industry. The objective is clear: to reduce waste, limit our environmental impact, and strengthen solidarity, while complying with a strict regulatory framework. An initial assessment now allows us to measure the tangible results of this collaboration. See the article announcing the launch of the project: https://entreprise.sagittapharma.com/un-partenariat-porteur-de-sens-pour-une-sante-plus-responsable-avec-pharmagreen/ The goal: to enable the reuse of unsellable pharmaceutical products destined for destruction, while having a real social and environmental impact. This initial assessment allows us to evaluate the concrete results of this collaboration. Giving pharmaceutical products a second life Launched with a strong environmental and societal ambition, the partnership between Sagitta Pharma and PharmaGreen aims to give unsellable but still usable pharmaceutical products a second life by redirecting them to secure solidarity channels. This initiative is fully in line with Sagitta Pharma's CSR strategy and consistent with the current challenges facing the industry: A structured system In six successive collections, 5,293 essential products were saved from destruction and reused in a supervised and solidarity-based framework. These products, which would have been disposed of through conventional channels, have thus found a new social purpose. A direct social impact thanks to partner associations The products collected were redistributed via three major associations in France and internationally: Thanks to these redistributions, thousands of people in precarious situations, isolated or in emergency situations, were able to access essential products, helping to improve their daily lives. Reuse and the environment: a measurable impact Beyond the social issue, the reuse of products directly contributes to reducing Sagitta Pharma's environmental footprint. At the end of December, the first collections had prevented 445 kg of CO₂ emissions, according to the system's consolidated data.This impact corresponds in particular to: These indicators make the environmental impact of reuse tangible, in line with a logic of sobriety and the circular economy. A CSR approach integrated into Sagitta Pharma's business This partnership is fully in line with Sagitta Pharma's CSR strategy, which is based on three pillars: In line with this approach, Sagitta Pharma also allows its customers to access this reuse system, offering them a simple, structured solution that is adapted to the operational constraints of pharmacies. An approach now open to Sagitta Pharma customers Since early 2026, the Pharmagreen system has been available to Sagitta Pharma customers, allowing them to easily integrate this responsible approach into their professional practice, while benefiting from a secure regulatory framework. A dynamic set to continue This initial assessment confirms the relevance of this approach to environmental and social responsibility, integrated into the realities on the ground. In 2026, we intend to continue our partnership with PharmaGreen, with the ambition of further strengthening its impact in the service of a more responsible, committed, and supportive pharmaceutical industry.

The end of the year is an opportunity to take a step back. At Sagitta Pharma, 2025 was an intense year, marked by sustained activity and the continuous mobilization of our teams to meet exciting challenges. In our Sagitta Pharma 2025 Retrospective video, we look back on the key milestones of the past year.This visual format highlights the key events of 2025: A constantly growing community of pharmacies 2025 was a very dynamic year: Sagitta Pharma continues to bring together a growing number of pharmacies around its model. This development reflects the relevance of our positioning and the trust placed in us by pharmacists, in a context where the reliability of partners is a key issue. Sustained activity, reflecting our operational performance 2025 also saw an increase in the volume of logistics and commercial activity. These results are based on improved organization, close coordination between teams, and an ability to maintain a level of service consistent with Good Distribution Practices. Each order processed reflects the high standards that structure Sagitta Pharma's daily operations. A wide and constantly evolving product range 2025 also saw the expansion of our product range, with the addition of numerous items to meet the needs of pharmacies. We would like to highlight: This development is part of a process of continuous adaptation to the field, in order to better meet the expectations of pharmacies and patients. High-quality partners The year was also marked by close collaboration with our partner laboratories, which play a key role in the availability, quality, and competitiveness of our offering. PharmaSmile: our exclusive brand in development The Sagitta Pharma 2025 Retrospective video also highlights the evolution of PharmaSmile, the exclusive brand developed by Sagitta Pharma. This video also highlights the progress of PharmaSmile, Sagitta Pharma's exclusive brand, launched at the end of 2024, which has quickly and harmoniously integrated into our customers' pharmacy shelves, complementing their traditional brands. These results confirm the relevance of its positioning within the Sagitta Pharma offering. A year of continuity The Sagitta Pharma 2025 retrospective marks a milestone. The projects launched in 2025 are continuing, and 2026 is shaping up to be a continuation of the company's model and values.

Independent pharmacies face a silent but constant challenge: the erosion of margins. The solution is not necessarily to cut costs at all costs, but to manage them more intelligently. Here's why central purchasing groups are becoming a strategic lever.

A national campaign for a collective challenge Every year, tobacco remains the leading cause of avoidable death in France, responsible for around 75,000 deaths attributed to its consumption according to Santé publique France. The "Month Without Tobacco 2025" initiative returns in November 2025 for its 10ᵉ edition. This national campaign encourages and motivates smokers to quit for 30 days, whether on their own or with the help of Tabac info service services and the support of healthcare professionals, particularly pharmacists. The gamble is based on a simple but effective principle: 30 days without tobacco multiplies by 5 the chances of lasting cessation. The latest OFDT data (2025) show a steady decline in daily smoking. ➡️ This represents a relative drop of around 21% in 13 years, or almost 4 million fewer daily smokers, a positive development which underlines the effectiveness of public policies and prevention campaigns such as the No Smoking Month. The 2024 edition in figures Looking back over the past year, we can see how popular the previous year's edition was. These figures reflect a growing demand for personalized support and a greater role for pharmacists in the success of smoking cessation. The central role of the pharmacist during Smoke-Free Month The pharmacist is a key player in the prevention and support of smoking cessation, and during Smoke-Free Month his role extends far beyond dispensing: he becomes a local guide in the weaning process. Informing and motivating patients Informing your patients about the campaign is a good way to get them thinking about quitting smoking, and a simple discussion in the dispensary can trigger the process. Official posters and kits available on tabac-info-service.fr facilitate this communication. This close relationship makes the pharmacist a privileged partner in the success of Smoke-Free Month. Advise on suitable substitutes Each patient is unique. To anticipate demand in November, it is advisable to stock a variety of cessation products. The pharmacist assesses the patient's level of dependence and recommends the most appropriate nicotine replacement therapy (NRT): good advice on dosage and combination of forms is crucial to avoid relapse. Similarly, good logistical preparation in the pharmacy guarantees a rapid response to your patients' needs. Where to find the right products? 👉 Find all these products on your Sagitta purchasing center in the Category: Smoking cessation You'll find a complete selection to support your patients: nicotine substitutes, medical devices and useful supplements for smoking cessation. Useful resources These resources provide you with verified information to support your advice and direct your patients towards comprehensive support. FAQ - Smoke-Free Month 2025 1. When does Smoke-Free Month 2025 begin? Smoke-Free Month begins on November 1, 2025 and runs until November 30, 2025. 2. Why 30 days? Because 30 days without smoking multiplies by 5 the chances of quitting for good, according to Santé publique France. 3. What is the role of the pharmacist? To inform, advise and support patients in their cessation, thanks to his or her expertise and the proximity of the counter. 4. Which substitutes to recommend: Nicotine substitutes (patches, gums, lozenges, sprays, inhalers) adapted to the smoker's level of dependence. 5. Where can I find the campaign materials? pharmacies can order the kits free of charge via the Tabac Info service health professionals area: pro.tabac-info-service.fr 6. What are the participation figures? 134,000 smokers took part in the operation in 2024, marking a significant trend in mobilization. In short, Smoke-Free Month is more than just a campaign: it's a national public health event, and the figures confirm a lasting decline in smoking and the decisive role played by pharmacists in this collective support. At Sagitta Pharma, every exchange counts, every patch advised counts, and every patient supported is a victory.

📌 What is Pink October? A worldwide mobilization Every year, the month of October is adorned in pink to remind us of a major public health issue: the fight against breast cancer. The pink ribbon has become a universal symbol, embodying solidarity, prevention and hope. The story of Pink October began in 1992 in the United States, under the impetus of Alexandra Penney (Self Magazine) and Evelyn H. Lauder (Estée Lauder). The initiative soon spread internationally, and in 1994, France adopted Pink October with the "Le Cancer du Sein, Parlons-en" campaign. Today, Pink October is no longer just a symbolic campaign: it's a high point of collective mobilization where associations, institutions and healthcare professionals work together to promote early detection and support research. 📊 Breast cancer in figures: a public health priority Today, Pink October is no longer just a symbolic campaign: it's a time for collective mobilization, with associations, institutions and healthcare professionals working together to promote early detection and support research. Breast cancer remains the most common cancer in women, and is a major public health issue: 👉 These figures are a reminder of the crucial importance of prevention and organized screening, particularly between the ages of 50 and 74, with mammography every two years. 🔍 The main risk factors for breast cancer Several factors influence the risk of developing breast cancer: 📌 According to experts, nearly 20,000 cases could be avoided each year by acting on modifiable risk factors (lifestyle, prevention, physical activity). ⚕️ Therapeutic advances and medical research 💉 Innovative, personalized treatments In recent years, research has led to major advances: These approaches individualize treatments, reduce side effects and improve quality of life. 🌐 Artificial intelligence for diagnosis AI now plays a central role in: AI-assisted portable ultrasound devices are also being trialed to improve access to screening in under-medicalized areas. 🧑‍⚕️ The essential role of pharmacists during Pink October As local healthcare professionals, pharmacists are key players in this fight. Their role can be broken down into three main missions: 🎯 Raising awareness and providing information 🤝 Promoting screening 💬 Accompanying patients Pharmacists are also involved in local mobilization, putting up ribbons and posters, or organizing awareness-raising events. 🌍 Pink October: a collective movement for the future Pink October goes far beyond the scope of a simple annual campaign: it's a citizen, medical and associative mobilization that reminds everyone of the importance of prevention and solidarity. Everyone has a role to play: this month of October is an opportunity to remind everyone that the fight against breast cancer doesn't stop on October 31. It continues all year round, through: ✨ Together, patients, caregivers, associations and citizens, we make Pink October a real lever of hope and progress for tomorrow. ❓ FAQ - Pink October and breast cancer 1. Why is the month of October associated with the fight against breast cancer? Because since 1992, the pink ribbon has become a global symbol, worn every October to remind people of the importance of prevention and screening. 2. At what age should I have a mammogram? Between the ages of 50 and 74, every two years, as part of the organized screening program. 3. Can breast cancer be prevented? It can't be totally prevented, but a healthy lifestyle greatly reduces the risk. 4. What are the first warning signs to look out for? A nodule, a change in the skin or nipple, or an abnormal discharge should raise the alarm. 5. What role does artificial intelligence play in the fight against breast cancer? It improves early detection, helps personalize treatments and accelerates clinical research. 6. Why are pharmacists essential during Pink October? Because they are accessible, educational and a crucial relay for informing, guiding and supporting patients. 📚 Useful resources Amirehsan Ghasemi, et al. Explainable artificial intelligence in breast cancer detection and risk prediction: A systematic scoping review. Cancer Innovation 2024;3:e136

At Sagitta Pharma, we are convinced that a company has a role to play far beyond its primary mission. As a wholesaler-distributor, Sagitta Pharma has the capacity to go beyond its distribution role. At a time when environmental and social issues are more than ever at the heart of our concerns, we have decided to take concrete action to contribute to a more sustainable, supportive and respectful model. To reinforce this approach, we have chosen to take concrete action: to give a second life to our unsold, damaged or near-expiry products, instead of destroying them. That's why we decided to work with PharmaGreen, a company specializing in the recycling of pharmaceutical products. Thanks to this partnership, these products are collected and redistributed to local associations. We saw this partnership as an obvious choice. This type of initiative unites us around shared values of solidarity, respect and commitment. It's also a source of pride for us to work for a company that makes a commitment and gives meaning to every action. Because our unsold products can change lives. At Sagitta Pharma, we believe it is possible to combine performance and responsibility. With PharmaGreen, we are taking a further step towards a more sustainable, supportive and humane pharmacy. Together, let's build the healthcare of tomorrow: more respectful of resources, closer to real needs, and more human.

At Sagitta Pharma, we are convinced that social responsibility is not limited to environmental commitments. While we often talk about sustainable development, reducing our carbon footprint or responsible consumption, it is just as essential - in our eyes - to focus on another fundamental axis: the well-being of the people who bring the company to life on a daily basis. Taking care of our teams: a commitment Our CSR approach fully integrates this human dimension. It is based on a certainty: a high-performance, sustainable company is first and foremost one that takes care of the health, balance and fulfillment of its employees. In our pharmaceutical business, where productivity is a daily concern, it can be easy to fall prey to fatigue, isolation, chronic stress and a sedentary lifestyle. These are all risk factors for physical and mental health, which can have an impact on team commitment and the quality of work. At Sagitta Pharma, we have chosen to act upstream. We have a self-service gym available to all Sagitta Pharma employees. What's more, every week we offer our employees sports sessions supervised by a professional coach. Several sessions are offered to suit everyone's schedule. This regular appointment is much more than a simple break in the schedule: it's designed as a lever for well-being and team cohesion. The benefits are manifold: these sessions create a collective moment where hierarchies disappear, where benevolence takes precedence over performance, and where we rediscover the simple pleasure of moving together. A corporate culture aligned with our values By implementing this type of initiative, we aim to build a working environment where every employee can flourish. This approach is part of a broader vision: that of a committed company, aware of its social role and ready to put people at the heart of its approach. It's not a question of following a trend, but of building a responsible business model in which quality of working life is a strategic lever - in the service of both employees and collective performance. To go further, together.

Last April, Sagitta Pharma and PharmaSmile, our exclusive brand, had the honor of supporting an extraordinary human and sporting adventure: the Rallye Aïcha des Gazelles du Maroc. For more than 30 years, this unique race has brought together 100% female crews around a single challenge: to cross the desert without GPS, using only a map, a compass and a ruler. The aim? Find the checkpoints in the fewest possible kilometers. More than a rally, it's a true test of endurance, strategy and solidarity. We are proud to have sponsored Les Gazelles Filantes, an energetic and inspiring local duo consisting of Céline and Laetitia, for their first participation in this legendary challenge. Their determination and team spirit were a source of inspiration for all those who followed their adventure. In addition to its sporting achievements, the rally also represents a strong commitment to humanitarian action and solidarity. Thanks to the Cœur de Gazelles association, a medical caravan accompanies the race to provide care and prevention in the most remote Moroccan villages. We had the pleasure of meeting Céline and Laetitia before their departure, notably during a visit to our warehouse - a moment full of symbols and sharing. 📸 From April 11 to 24, we enthusiastically followed every stage of their adventure. Les Gazelles Filantes brilliantly finished 81st out of nearly 200 crews - a remarkable result for a first-time participant! Here's a look back at this wonderful adventure: Congratulations once again to Céline and Laetitia for their courage, tenacity and energy! 🌟

On May 28, World Action Day for Women's Health and World Menstrual Hygiene Day, we at Sagitta Pharma are reaffirming our conviction that health does not stop at the products we distribute, but is also reflected in the human values we uphold every day. Including menstrual health in everyday working life In the world of work, the question of menstrual precariousness is still too often taboo. Yet menstruation affects almost half the population (and even just over half at Sagitta Pharma 😉 ) and has a direct impact on quality of life at work, concentration, well-being and sometimes even attendance at work. Aware of this reality, for the past two years we have installed free sanitary protection dispensers in all the washrooms at our Fondettes site, for anyone who needs one. Why is this important? Because it responds to several crucial issues: This gesture may seem simple. But it is necessary to ensure that menstrual health is respected within the company. Health, inclusion, respect: our values come to life every day At Sagitta Pharma, health is our daily business. But we refuse to think of it solely as a supply chain. For us, health is embodied in the quality of life we offer our teams, and in the attention we pay to the real needs of our employees. Just as [Claripharm] sports classes promote well-being and solidarity, this inclusive approach ensures that every employee, whatever their status or situation, can work in dignified, healthy and respectful conditions. It is in this spirit that we have chosen to collaborate with Laboratoire Claripharm™, a committed company that supports other structures in implementing concrete actions against menstrual precariousness. Professional equality cannot be decreed, it has to be built. And every initiative contributes to it. At Sagitta Pharma, we believe in global, inclusive and responsible health. And that starts with taking care of each other.